Use of electromagnetic fields in cancer and other therapies
First Claim
Patent Images
1. Apparatus for establishing a plurality of electromagnetic (EM) fields to provide a region of bio-effectiveness in a human or animal body, the apparatus comprising;
- means to generate a first EM field encompassing in part a region in a human or animal body wherein bio-effectiveness is to be achieved, means to generate at least one additional EM field also in part encompassing in part said region, means for modulating the first field to cause it to be at a first magnitude for a first period of time and at a second magnitude for a following period of time, with changes occurring with approximately 10 second intervals, means for modulating the additional field to cause it to be at a first magnitude for a first period of time and at a second magnitude for a following period of time, with changes occurring within approximately 10 second intervals, means for controlling said modulation means to cause the magnitude of the first EM field and the magnitude of the additional field at all given times to be complementary in respect of time, whereby within said region the respective fields will provide a combined field having a predetermined pattern of limited differences in magnitudes but outside the region the respective fields will alternate between said first and second magnitudes.
1 Assignment
0 Petitions
Accused Products
Abstract
Methods and apparatus are described for the treatment of diseases by exposures to electromagnetic fields. Also, apparatus is described for focusing the biological effectiveness of such fields on specific cells, tissues or organs of a human or animal body.
-
Citations
25 Claims
-
1. Apparatus for establishing a plurality of electromagnetic (EM) fields to provide a region of bio-effectiveness in a human or animal body, the apparatus comprising;
-
means to generate a first EM field encompassing in part a region in a human or animal body wherein bio-effectiveness is to be achieved, means to generate at least one additional EM field also in part encompassing in part said region, means for modulating the first field to cause it to be at a first magnitude for a first period of time and at a second magnitude for a following period of time, with changes occurring with approximately 10 second intervals, means for modulating the additional field to cause it to be at a first magnitude for a first period of time and at a second magnitude for a following period of time, with changes occurring within approximately 10 second intervals, means for controlling said modulation means to cause the magnitude of the first EM field and the magnitude of the additional field at all given times to be complementary in respect of time, whereby within said region the respective fields will provide a combined field having a predetermined pattern of limited differences in magnitudes but outside the region the respective fields will alternate between said first and second magnitudes. - View Dependent Claims (2, 3, 4, 5)
-
- 6. Apparatus for use in anti-cancer treatments, comprising means for exposing both normal and diseased tissues to EM fields for a minimum of 20 minutes, with the field exposure ending at a maximum of 10 hours prior to treatment with therapeutic agents, the generating means including two EM field source configurations.
-
11. Apparatus for exposure of EM fields to tissue, including means for generating circular polarized fields for a minimum of 20 minutes and a maximum of 10 hours, the generating means including two EM field source configurations in different orientations.
- 12. Apparatus for focusing the biological effect on cells, tissues or organs with an applied time varying EM field resulting from the superimposition of two biologically ineffective time varying fields when applied separately, the fields being generated from a primary source configuration producing a spatially varying EM field and from a secondary source configuration producing a second spatially varying EM field of the same frequency and waveform as the primary source configuration, with the primary and secondary field amplitudes being within 25% of being equal only on the targeted cells, tissues and organs.
Specification